Corporation
Lifestyle
"From Efficacy Failures to Controversy Over Internal Analysis"... Kolon TissueGene's U.S. Phase 3 Trial Objectivity Under Scrutiny
Kolon TissueGene CI (Photo courtesy of Kolon TissueGene)
Kolon TissueGene’s TG-C, a cell-gene therapy for osteoarthritis, failed to demonstrate efficacy in the first topline results from its U.S. …
- 2026-07-21 10:01:03
- SONG YOUNG-DOO
Electronics
SamsungElectronics Wins Daesang for Eighth Consecutive Year, Led by AI Home Appliances
SamsungElectronics has won the “Daesang” for the eighth consecutive year, led by its home appliances featuring AI-based energy-saving technology. A wide range of AI appliances—including air conditione…
- 2026-07-21 10:00:04
- JAEMIN SONG
Lifestyle
VIVOZON PHARMACEUTICAL Launches “Lara Pang Tablets,” a Tablet-Form Bowel Cleansing Agent Designed for Ease of Use
VIVOZON PHARMACEUTICAL(082800)announced on the 21st that it will launch “Lalafang,” a tablet-form bowel preparation.Lalapang Tablets received marketing authorization from the Ministry of Food and Drug…
- 2026-07-21 09:43:01
- NA EUN-KYUNG
Lifestyle
National Cigarette Brand ‘Dis’ Now Imported… KT&G Corporation Shifts Production to the U.S.
KT&G Corporation is manufacturing its flagship cigarette brands, “THIS” and “THIS Plus,” in the United States and importing them into South Korea. Including “Hogshead,” which was launched last year, t…
- 2026-07-21 09:01:18
- SIN SOO-JUNG
Lifestyle
BARREL Co., Ltd. Launches Full-Scale Distribution Business in China… Opens Official Tmall Store
The water sports brand BARREL Co., Ltd.(267790)has shipped its first batch of products as part of its China distribution business and launched local online sales. In September, the company plans to in…
- 2026-07-21 09:00:13
- Kim Ji-woo
Lifestyle
Celltrion and Samsung, Not SMEs, Benefit from Biosimilar Phase 3 Exemption... Why?
With the official announcement of the Phase 3 clinical trial exemption for biosimilars, biosimilar companies are busy crunching the numbers. On the 14th, South Korea’s Ministry of Food and Drug Safety…
- 2026-07-21 08:36:02
- SONG YOUNG-DOO
Lifestyle
"Banana Milk and Ramen by the Sea"... GS25 Sees 136.9% Increase in Sales to Foreigners at Coastal Stores
As the summer vacation season kicks off, convenience store sales have surged significantly amid a rise in foreign tourists visiting coastal areas.
Foreign tourists are purchasing items at GS25. (Ph…
- 2026-07-21 08:35:27
- Kim Ji-woo
Lifestyle
[Blue Ocean Veterinary Medical Devices] ① Jeong Byeong-gon, President of the Korea Veterinary Medicines Association: “Focus on ‘Animal-Specific’ Products Derived from Human Medicines”
As medical technology advances, the treatment of human diseases is rapidly evolving into the era of “personalized medicine” and “precision medicine.” This shift is now spreading to the field of veteri…
- 2026-07-21 07:02:02
- Kim Jinsoo
Lifestyle
'Largest Domestic M&A Deal': Samsung Bio, With Peptide Business, Solidifies Its Position as the World's No. 1 CDMO
SAMSUNG BIOLOGICS(207940)has signed the largest merger and acquisition (M&A) deal in South Korea’s pharmaceutical and biotech industry to produce peptide drugs, which are well known as ingredients in …
- 2026-07-20 18:00:03
- Kim Jinsoo
Lifestyle
Kolon TissueGene, Inc. Fails to Demonstrate Statistical Efficacy in Topline Results from U.S. Phase 3 Clinical Trial of ‘TG-C’ for Knee Osteoarthritis
“TG-C,” a cell-gene therapy candidate for knee osteoarthritis developed by Kolon TissueGene, Inc.(950160)—better known as Inbosa—failed to meet the primary efficacy endpoint in the topline results of …
- 2026-07-20 17:30:16
- YU JIN-HEE
PHARM EDAILY
Shorts